Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

1.0K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
1.0K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

40
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
40
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

64
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
64
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

58
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
58
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

42
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
42

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Antioxidant Paradox in Soccer: Striking the Balance between Protection and Performance.

Combinatorial chemistry & high throughput screening·2026
Same author

Artificial Intelligence in Medication Research and Development: The Pharmaceutical Industry's Future.

Current medicinal chemistry·2026
Same author

Characteristic Correlation between Staphylococcal Isolates from Wounds and Nares of Diabetic Foot Patients Living in Erbil City, Iraq.

Current diabetes reviews·2026
Same author

Disinfectant/antiseptic resistance genes of Staphylococci and serotyping of clinical Staphylococcus aureus isolates.

Journal of infection in developing countries·2026
Same author

Examination of Genetic Mutations of Clofazimine Resistance in Drug-Resistant Mycobacterium TB Isolates.

Current microbiology·2025
Same author

Determination of Potential Inhibitors against Mycobacterium tuberculosis, Staphylococcus aureus, and Helicobacter pylori Shikimate Dehydrogenase by using Virtual Screening.

Current pharmaceutical design·2025

Related Experiment Video

Updated: Jul 21, 2025

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

11.9K

Bacterial Pathogens: Potential Source For Antimicrobial Peptides.

Manaf AlMatar1, Osman Albarri2, Raja Lakhal1

  • 1Faculty of Education and Art, Sohar University, Sohar, 311, Sultanate of Oman.

Current Protein & Peptide Science
|July 27, 2023
PubMed
Summary

Pathogenic bacteria, though a threat, are a rich source for new antibiotics. Exploring these microbes and their specialized metabolites offers a promising solution to combat antimicrobial resistance.

Keywords:
Bacterial pathogensalternative therapiesantimicrobial peptidesbacterial genomesdrug resistancenonribosomal peptides

More Related Videos

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

12.5K
Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

10.4K

Related Experiment Videos

Last Updated: Jul 21, 2025

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

11.9K
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

12.5K
Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

10.4K

Area of Science:

  • Microbiology and Pharmacology
  • Drug Discovery and Development

Background:

  • Antimicrobial resistance (AMR) necessitates novel therapeutic strategies.
  • The pipeline for new antibiotics is critically depleted.
  • Pathogenic bacteria represent an underutilized resource for novel drug discovery.

Approach:

  • Review of specialized metabolites from pathogenic bacteria with antibacterial activity.
  • Focus on compounds in pre-clinical studies or with drug development potential.
  • Discussion of atypical biosynthetic pathways, functions, mechanisms of action, and activities.

Key Points:

  • Pathogenic bacteria harbor a vast reservoir of potential antimicrobial compounds.
  • Specialized metabolites from these bacteria show significant antibacterial promise.
  • Genomic and natural product research methods accelerate discovery.

Conclusions:

  • Pathogenic bacteria are a viable and promising source for new antibiotic development.
  • Further research into bacterial metabolites can combat the AMR crisis.
  • A new era of antibiotic discovery is possible through exploring these microbial sources.